Integrative development of a short screening questionnaire of highly processed food consumption (sQ-HPF).

Food processing-based classification Highly processed food NOVA PREDIMED-Plus Questionnaire Ultra-processed food

Journal

The international journal of behavioral nutrition and physical activity
ISSN: 1479-5868
Titre abrégé: Int J Behav Nutr Phys Act
Pays: England
ID NLM: 101217089

Informations de publication

Date de publication:
24 01 2022
Historique:
received: 22 07 2021
accepted: 14 12 2021
entrez: 25 1 2022
pubmed: 26 1 2022
medline: 8 4 2022
Statut: epublish

Résumé

Recent lifestyle changes include increased consumption of highly processed foods (HPF), which has been associated with an increased risk of non-communicable diseases (NCDs). However, nutritional information relies on the estimation of HPF consumption from food-frequency questionnaires (FFQ) that are not explicitly developed for this purpose. We aimed to develop a short screening questionnaire of HPF consumption (sQ-HPF) that integrates criteria from the existing food classification systems. Data from 4400 participants (48.1% female and 51.9% male, 64.9 ± 4.9 years) of the Spanish PREDIMED-Plus ("PREvention with MEDiterranean DIet") trial were used for this analysis. Items from the FFQ were classified according to four main food processing-based classification systems (NOVA, IARC, IFIC and UNC). Participants were classified into tertiles of HPF consumption according to each system. Using binomial logistic regression, food groups associated with agreement in the highest tertile for at least two classification systems were chosen as items for the questionnaire. ROC analysis was used to determine cut-off points for the frequency of consumption of each item, from which a score was calculated. Internal consistency of the questionnaire was assessed through exploratory factor analysis (EFA) and Cronbach's analysis, and agreement with the four classifications was assessed with weighted kappa coefficients. Regression analysis identified 14 food groups (items) associated with high HPF consumption for at least two classification systems. EFA showed that items were representative contributors of a single underlying factor, the "HPF dietary pattern" (factor loadings around 0.2). We constructed a questionnaire asking about the frequency of consumption of those items. The threshold frequency of consumption was selected using ROC analysis. Comparison of the four classification systems and the sQ-HPF showed a fair to high agreement. Significant changes in lifestyle characteristics were detected across tertiles of the sQ-HPF score. Longitudinal changes in HPF consumption were also detected by the sQ-HPF, concordantly with existing classification systems. We developed a practical tool to measure HPF consumption, the sQ-HPF. This may be a valuable instrument to study its relationship with NCDs. Retrospectively registered at the International Standard Randomized Controlled Trial Registry ( ISRCTN89898870 ) on July 24, 2014.

Sections du résumé

BACKGROUND
Recent lifestyle changes include increased consumption of highly processed foods (HPF), which has been associated with an increased risk of non-communicable diseases (NCDs). However, nutritional information relies on the estimation of HPF consumption from food-frequency questionnaires (FFQ) that are not explicitly developed for this purpose. We aimed to develop a short screening questionnaire of HPF consumption (sQ-HPF) that integrates criteria from the existing food classification systems.
METHODS
Data from 4400 participants (48.1% female and 51.9% male, 64.9 ± 4.9 years) of the Spanish PREDIMED-Plus ("PREvention with MEDiterranean DIet") trial were used for this analysis. Items from the FFQ were classified according to four main food processing-based classification systems (NOVA, IARC, IFIC and UNC). Participants were classified into tertiles of HPF consumption according to each system. Using binomial logistic regression, food groups associated with agreement in the highest tertile for at least two classification systems were chosen as items for the questionnaire. ROC analysis was used to determine cut-off points for the frequency of consumption of each item, from which a score was calculated. Internal consistency of the questionnaire was assessed through exploratory factor analysis (EFA) and Cronbach's analysis, and agreement with the four classifications was assessed with weighted kappa coefficients.
RESULTS
Regression analysis identified 14 food groups (items) associated with high HPF consumption for at least two classification systems. EFA showed that items were representative contributors of a single underlying factor, the "HPF dietary pattern" (factor loadings around 0.2). We constructed a questionnaire asking about the frequency of consumption of those items. The threshold frequency of consumption was selected using ROC analysis. Comparison of the four classification systems and the sQ-HPF showed a fair to high agreement. Significant changes in lifestyle characteristics were detected across tertiles of the sQ-HPF score. Longitudinal changes in HPF consumption were also detected by the sQ-HPF, concordantly with existing classification systems.
CONCLUSIONS
We developed a practical tool to measure HPF consumption, the sQ-HPF. This may be a valuable instrument to study its relationship with NCDs.
TRIAL REGISTRATION
Retrospectively registered at the International Standard Randomized Controlled Trial Registry ( ISRCTN89898870 ) on July 24, 2014.

Identifiants

pubmed: 35073909
doi: 10.1186/s12966-021-01240-6
pii: 10.1186/s12966-021-01240-6
pmc: PMC8785596
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Informations de copyright

© 2022. The Author(s).

Références

J Am Coll Cardiol. 2021 Mar 30;77(12):1520-1531
pubmed: 33766258
PLoS One. 2014 Mar 25;9(3):e92752
pubmed: 24667658
Nutr J. 2020 Aug 20;19(1):86
pubmed: 32819372
PLoS Med. 2016 Jun 07;13(6):e1002036
pubmed: 27270749
Curr Dev Nutr. 2018 Sep 14;3(2):nzy077
pubmed: 30820487
PLoS One. 2017 Jan 13;12(1):e0168148
pubmed: 28085886
Public Health Nutr. 2012 Jan;15(1):82-7
pubmed: 21752314
J Nutr. 2014 Mar;144(3):399-407
pubmed: 24453128
Nutr Cancer. 2011 Nov;63(8):1235-50
pubmed: 22043987
Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Int J Behav Nutr Phys Act. 2017 Dec 11;14(1):168
pubmed: 29228998
Occup Environ Med. 2005 Apr;62(4):272-80, 212-4
pubmed: 15778263
Eur J Nutr. 2021 Oct;60(7):4045-4054
pubmed: 33959803
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
Obes Rev. 2020 Dec;21(12):e13126
pubmed: 32761763
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Public Health Nutr. 2011 Jan;14(1):5-13
pubmed: 21211100
J Pers Assess. 1992 Feb;58(1):27-35
pubmed: 1545342
Mayo Clin Proc. 2019 Nov;94(11):2178-2188
pubmed: 31623843
BMJ Open. 2018 Mar 9;8(3):e020574
pubmed: 29525772
Rev Saude Publica. 2021 Aug 16;55:51
pubmed: 34406278
Nutrients. 2021 Jul 20;13(7):
pubmed: 34371982
Implement Sci. 2016 Feb 04;11:15
pubmed: 26846789
JAMA Intern Med. 2019 Apr 1;179(4):490-498
pubmed: 30742202
Public Health Nutr. 2018 Jan;21(1):125-133
pubmed: 28625223
Nutrients. 2015 Nov 17;7(11):9523-37
pubmed: 26593942
J Acad Nutr Diet. 2018 Sep;118(9):1591-1602
pubmed: 30146071
Int J Behav Nutr Phys Act. 2021 Jun 7;18(1):70
pubmed: 34092234
Am J Clin Nutr. 2016 Nov;104(5):1433-1440
pubmed: 27733404
Rev Saude Publica. 2015;49:38
pubmed: 26176747
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
Can J Diet Pract Res. 2014 Spring;75(1):15-21
pubmed: 24606955
Adv Nutr. 2015 Nov 13;6(6):629-38
pubmed: 26567188
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
BMJ Open. 2019 Aug 28;9(8):e029544
pubmed: 31462476
Am J Clin Nutr. 2021 Jul 1;114(1):80-89
pubmed: 33964853
Prev Chronic Dis. 2006 Oct;3(4):A118
pubmed: 16978493
Clin Nutr. 2021 Aug;40(8):4971-4979
pubmed: 34364236
Int J Epidemiol. 1993 Jun;22(3):512-9
pubmed: 8359969
Eur J Clin Nutr. 2009 Nov;63 Suppl 4:S206-25
pubmed: 19888275
PLoS One. 2018 Jun 18;13(6):e0198974
pubmed: 29912978
Int J Behav Nutr Phys Act. 2016 May 06;13:57
pubmed: 27151280
Nutrients. 2015 Dec 02;7(12):10076-88
pubmed: 26633491
Eur J Clin Nutr. 2020 Dec;74(12):1653-1660
pubmed: 32322049
Nutrients. 2019 Jun 07;11(6):
pubmed: 31181631
Public Health Nutr. 2018 Jan;21(1):27-37
pubmed: 28703085
Clin Rheumatol. 2020 May;39(5):1423-1428
pubmed: 31902026
Eur J Nutr. 2021 Oct;60(7):3927-3934
pubmed: 33904995
Am J Hypertens. 2017 Apr 1;30(4):358-366
pubmed: 27927627
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
BMJ. 2018 Feb 14;360:k322
pubmed: 29444771
Am J Gastroenterol. 2018 Aug;113(8):1217-1228
pubmed: 29904158
Eur J Clin Nutr. 2018 Oct;72(10):1404-1412
pubmed: 29277837
J Nutr. 2012 Nov;142(11):2065S-2072S
pubmed: 22990468
Lancet Diabetes Endocrinol. 2021 Jul;9(7):462-470
pubmed: 33865500
Health Educ Monogr. 1978 Spring;6(2):160-70
pubmed: 689890
Public Health Nutr. 2018 Jan;21(1):5-17
pubmed: 28322183
Public Health Nutr. 2006 Feb;9(1A):152-7
pubmed: 16512963
Prev Med. 2015 Dec;81:9-15
pubmed: 26231112
Am J Clin Nutr. 2015 Jun;101(6):1251-62
pubmed: 25948666
Am J Clin Nutr. 2017 Sep;106(3):717-724
pubmed: 28793996
Public Health Nutr. 2015 Dec;18(17):3096-107
pubmed: 25804833
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123
BMJ. 2019 May 29;365:l1451
pubmed: 31142457

Auteurs

Celia Martinez-Perez (C)

Nutritional Genomics and Epigenomics Group, Precision Nutrition and Obesity Program, IMDEA Food, CEI UAM + CSIC, Ctra. Cantoblanco, 8, 28049, Madrid, Spain.

Lidia Daimiel (L)

Nutritional Genomics and Epigenomics Group, Precision Nutrition and Obesity Program, IMDEA Food, CEI UAM + CSIC, Ctra. Cantoblanco, 8, 28049, Madrid, Spain. lidia.daimiel@imdea.org.

Cristina Climent-Mainar (C)

Nutritional Genomics and Epigenomics Group, Precision Nutrition and Obesity Program, IMDEA Food, CEI UAM + CSIC, Ctra. Cantoblanco, 8, 28049, Madrid, Spain.

Miguel Ángel Martínez-González (MÁ)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IdiSNA, 31009, Pamplona, Spain.
Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.

Jordi Salas-Salvadó (J)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Unitat de Nutrició Humana, Departament de Bioquímica i biotecnologia, Universitat Rovira i Virgili, 43201, Reus, Spain.
Human Nutrition Unit, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204, Reus, Spain.

Dolores Corella (D)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, 46010, Valencia, Spain.

Helmut Schröder (H)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.

Jose Alfredo Martinez (JA)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Cardiometabolic Nutrition Group, IMDEA Food, CEI UAM + CSIC, 28049, Madrid, Spain.
Department of Nutrition, Food Sciences and Physiology, University of Navarra, 31009, Pamplona, Spain.

Ángel M Alonso-Gómez (ÁM)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 01009, Vitoria-Gasteiz, Spain.

Julia Wärnberg (J)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Nursing, School of Health Sciences, University of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29016, Málaga, Spain.

Jesús Vioque (J)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-UMH), 03010, Alicante, Spain.

Dora Romaguera (D)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology (NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120, Palma de Mallorca, Spain.

José López-Miranda (J)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14017, Córdoba, Spain.

Ramón Estruch (R)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08007, Barcelona, Spain.

Francisco J Tinahones (FJ)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Endocrinology, Instituto de Investigación Biomédica de Málaga (IBIMA), Virgen de la Victoria Hospital, University of Málaga, 29016, Málaga, Spain.

José Lapetra (J)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013, Sevilla, Spain.

Lluis Serra-Majem (L)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, Preventive Medicine Service, Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service, 35016, Las Palmas, Spain.

Aurora Bueno-Cavanillas (A)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, 18011, Granada, Spain.

Josep A Tur (JA)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands-IUNICS & IDISBA, 07122, Palma de Mallorca, Spain.

Vicente Martín Sánchez (VM)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Institute of Biomedicine (IBIOMED), University of León, 24071, León, Spain.

Xavier Pintó (X)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, 08907, Barcelona, Spain.

Miguel Delgado-Rodríguez (M)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Departamento de Ciencias de la Salud, Centro de Estudios Avanzados en Olivar y Aceites de Oliva, Universidad de Jaén, 23071, Jaén, Spain.

Pilar Matía-Martín (P)

Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040, Madrid, Spain.

Josep Vidal (J)

Biomedical Research Centre for Diabetes and Metabolic Diseases Network (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Endocrinology and Nutrition Service, IDIBAPS, Hospital Clinic, University of Barcelona, 08007, Barcelona, Spain.

Clotilde Vázquez (C)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Endocrinology and Nutrition, Hospital Fundación Jimenez Díaz, Instituto de Investigaciones Biomédicas IISFJD, University Autónoma, 28015, Madrid, Spain.

Emilio Ros (E)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Endocrinology and Nutrition Service, IDIBAPS, Hospital Clinic, University of Barcelona, 08007, Barcelona, Spain.

Javier Basterra (J)

Department of Preventive Medicine and Public Health, University of Navarra, IdiSNA, 31009, Pamplona, Spain.
Department of Endocrinology and Nutrition, Complejo Hospitalario de Navarra, 31008, Pamplona, Spain.

Nancy Babio (N)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Unitat de Nutrició Humana, Departament de Bioquímica i biotecnologia, Universitat Rovira i Virgili, 43201, Reus, Spain.
Human Nutrition Unit, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204, Reus, Spain.

Patricia Guillem-Saiz (P)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, 46010, Valencia, Spain.

María Dolores Zomeño (MD)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.
School of Health Sciences, Blanquerna-Ramon Llull University, 08001, Barcelona, Spain.

Itziar Abete (I)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Nutrition, Food Sciences and Physiology, University of Navarra, 31009, Pamplona, Spain.

Jessica Vaquero-Luna (J)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 01009, Vitoria-Gasteiz, Spain.

Francisco Javier Barón-López (FJ)

Department of Public Health, University of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29016, Málaga, Spain.

Sandra Gonzalez-Palacios (S)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-UMH), 03010, Alicante, Spain.

Jadwiga Konieczna (J)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology (NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120, Palma de Mallorca, Spain.

Antonio Garcia-Rios (A)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14017, Córdoba, Spain.

María Rosa Bernal-López (MR)

Internal Medicine Department, Regional University Hospital of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010, Málaga, Spain.

José Manuel Santos-Lozano (JM)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013, Sevilla, Spain.

Maira Bes-Rastrollo (M)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IdiSNA, 31009, Pamplona, Spain.

Nadine Khoury (N)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Unitat de Nutrició Humana, Departament de Bioquímica i biotecnologia, Universitat Rovira i Virgili, 43201, Reus, Spain.
Human Nutrition Unit, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204, Reus, Spain.

Carmen Saiz (C)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, 46010, Valencia, Spain.

Karla Alejandra Pérez-Vega (KA)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.

María Angeles Zulet (MA)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Nutrition, Food Sciences and Physiology, University of Navarra, 31009, Pamplona, Spain.

Lucas Tojal-Sierra (L)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 01009, Vitoria-Gasteiz, Spain.

Zenaida Vázquez Ruiz (ZV)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IdiSNA, 31009, Pamplona, Spain.

Maria Angeles Martinez (MA)

Biomedical Research Centre for Obesity Physiopathology and Nutrition Network (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
Unitat de Nutrició Humana, Departament de Bioquímica i biotecnologia, Universitat Rovira i Virgili, 43201, Reus, Spain.
Human Nutrition Unit, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43204, Reus, Spain.

Mireia Malcampo (M)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.

José M Ordovás (JM)

Nutritional Genomics and Epigenomics Group, Precision Nutrition and Obesity Program, IMDEA Food, CEI UAM + CSIC, Ctra. Cantoblanco, 8, 28049, Madrid, Spain.
Nutrition and Genomics Laboratory, JM_USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, 02155, USA.

Rodrigo San-Cristobal (R)

Cardiometabolic Nutrition Group, IMDEA Food, CEI UAM + CSIC, 28049, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH